Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...
Reexamination Certificate
2005-07-15
2009-11-17
Yu, Misook (Department: 1642)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
C424S143100
Reexamination Certificate
active
07618626
ABSTRACT:
The present invention relates to a therapeutic method for the treatment of non-hematologic malignancies comprising administering anti-IGF-1R antibodies, particularly human anti-IGF-1R antibodies, to a patient, in conjunction with the administration of at least one other therapeutic agent. The invention further relates to pharmaceutical compositions comprising these antibodies and methods of using such compositions thereof for treatment.
REFERENCES:
patent: 4399216 (1983-08-01), Axel et al.
patent: 4510245 (1985-04-01), Cousens et al.
patent: 4634665 (1987-01-01), Axel et al.
patent: 4740461 (1988-04-01), Kaufman
patent: 4912040 (1990-03-01), Kaufman et al.
patent: 4959455 (1990-09-01), Clark et al.
patent: 4968516 (1990-11-01), Koszinoski et al.
patent: 5151510 (1992-09-01), Stec et al.
patent: 5168062 (1992-12-01), Stinski
patent: 5179017 (1993-01-01), Axel et al.
patent: 5223409 (1993-06-01), Ladner et al.
patent: 5530101 (1996-06-01), Queen et al.
patent: 5545806 (1996-08-01), Lonberg et al.
patent: 5545807 (1996-08-01), Surani et al.
patent: 5585089 (1996-12-01), Queen et al.
patent: 5587458 (1996-12-01), King et al.
patent: 5591669 (1997-01-01), Krimpenfort et al.
patent: 5612205 (1997-03-01), Kay et al.
patent: 5625126 (1997-04-01), Lonberg et al.
patent: 5625825 (1997-04-01), Rostoker et al.
patent: 5633425 (1997-05-01), Lonberg et al.
patent: 5643763 (1997-07-01), Dunn et al.
patent: 5661016 (1997-08-01), Lonberg et al.
patent: 5693761 (1997-12-01), Queen et al.
patent: 5693792 (1997-12-01), Torii et al.
patent: 5714350 (1998-02-01), Co et al.
patent: 5721367 (1998-02-01), Kay et al.
patent: 5741957 (1998-04-01), Deboer et al.
patent: 5747498 (1998-05-01), Schnuer
patent: 5750172 (1998-05-01), Meade et al.
patent: 5756687 (1998-05-01), Denman et al.
patent: 5770429 (1998-06-01), Lonberg et al.
patent: 5777085 (1998-07-01), Co et al.
patent: 5789215 (1998-08-01), Berns et al.
patent: 5789650 (1998-08-01), Lonberg et al.
patent: 5792783 (1998-08-01), Tang et al.
patent: 5814318 (1998-09-01), Lonberg et al.
patent: 5827690 (1998-10-01), Meade et al.
patent: 5834504 (1998-11-01), Tang et al.
patent: 5861510 (1999-01-01), Piscopio et al.
patent: 5863949 (1999-01-01), Robinson et al.
patent: 5877305 (1999-03-01), Huston et al.
patent: 5883113 (1999-03-01), Tang et al.
patent: 5886020 (1999-03-01), Tang et al.
patent: 5886152 (1999-03-01), Nakatani et al.
patent: 5916771 (1999-06-01), Hori et al.
patent: 5939598 (1999-08-01), Kucherlapati et al.
patent: 5985615 (1999-11-01), Jakobovits et al.
patent: 5994619 (1999-11-01), Stice et al.
patent: 5998209 (1999-12-01), Jokobovits et al.
patent: 6054297 (2000-04-01), Carter et al.
patent: 6054561 (2000-04-01), Ring
patent: 6075181 (2000-06-01), Kucherlapati et al.
patent: 6084085 (2000-07-01), Baserga et al.
patent: 6091001 (2000-07-01), Jakobovits et al.
patent: 6114598 (2000-09-01), Kucherlapati et al.
patent: 6130364 (2000-10-01), Jakobovits et al.
patent: 6146629 (2000-11-01), Dagan et al.
patent: 6657103 (2003-12-01), Kucherlapati et al.
patent: 2003/0165502 (2003-09-01), Fujita-Yamaguchi
patent: 2003/0235582 (2003-12-01), Singh
patent: 2004/0086503 (2004-05-01), Cohen et al.
patent: 2004/0202655 (2004-10-01), Morton et al.
patent: 2004/0228859 (2004-11-01), Graus et al.
patent: 2005/0069539 (2005-03-01), Cohen et al.
patent: 0216846 (1987-04-01), None
patent: 0256055 (1988-02-01), None
patent: 0323997 (1989-07-01), None
patent: 0338841 (1989-10-01), None
patent: 0606046 (1994-07-01), None
patent: 0780386 (1997-06-01), None
patent: 0818442 (1998-01-01), None
patent: 0931788 (1999-07-01), None
patent: 1004578 (2000-05-01), None
patent: WO 9005719 (1990-05-01), None
patent: WO 9109967 (1991-07-01), None
patent: WO 9110741 (1991-07-01), None
patent: WO 9117271 (1991-11-01), None
patent: WO 9201047 (1992-01-01), None
patent: WO 9202190 (1992-02-01), None
patent: WO 9209690 (1992-06-01), None
patent: WO 9215679 (1992-09-01), None
patent: WO 9218619 (1992-10-01), None
patent: WO 9220791 (1992-11-01), None
patent: WO 9301288 (1993-01-01), None
patent: WO 9306213 (1993-04-01), None
patent: WO 9317105 (1993-09-01), None
patent: WO 9402602 (1994-02-01), None
patent: WO 9519970 (1995-07-01), None
patent: WO 9521613 (1995-08-01), None
patent: WO 9627583 (1996-09-01), None
patent: WO 9633172 (1996-10-01), None
patent: WO 9633735 (1996-10-01), None
patent: WO 9634096 (1996-10-01), None
patent: WO 9713760 (1997-04-01), None
patent: WO 9722596 (1997-06-01), None
patent: WO 9732856 (1997-09-01), None
patent: WO 9802434 (1998-01-01), None
patent: WO 9802437 (1998-01-01), None
patent: WO 9802438 (1998-01-01), None
patent: WO 9803516 (1998-01-01), None
patent: WO 9807697 (1998-02-01), None
patent: WO 9814451 (1998-04-01), None
patent: WO 9816654 (1998-04-01), None
patent: WO 9824893 (1998-06-01), None
patent: WO 9830566 (1998-07-01), None
patent: WO 9833768 (1998-08-01), None
patent: WO 9834915 (1998-08-01), None
patent: WO 9834918 (1998-08-01), None
patent: WO 9850356 (1998-11-01), None
patent: WO 9850433 (1998-11-01), None
patent: WO 9854093 (1998-12-01), None
patent: WO 9907675 (1999-02-01), None
patent: WO 9910349 (1999-03-01), None
patent: WO 9916755 (1999-04-01), None
patent: WO 9924440 (1999-05-01), None
patent: WO 9929667 (1999-06-01), None
patent: WO 9935132 (1999-07-01), None
patent: WO 9935146 (1999-07-01), None
patent: WO 9945031 (1999-09-01), None
patent: WO 9952889 (1999-10-01), None
patent: WO 9952910 (1999-10-01), None
patent: WO 9953049 (1999-10-01), None
patent: WO 9960023 (1999-11-01), None
patent: WO 9961422 (1999-12-01), None
patent: WO 9962890 (1999-12-01), None
patent: WO 0009560 (2000-02-01), None
patent: WO 0037504 (2000-06-01), None
patent: WO0050067 (2000-08-01), None
patent: WO 0056772 (2000-09-01), None
patent: WO 02/053596 (2002-07-01), None
patent: WO 02053596 (2002-07-01), None
patent: WO 03059951 (2003-07-01), None
patent: WO 03093317 (2003-11-01), None
patent: WO 03100008 (2003-12-01), None
patent: WO 03100059 (2003-12-01), None
patent: WO 03106621 (2003-12-01), None
patent: WO 2004071529 (2004-08-01), None
patent: WO 2004087756 (2004-10-01), None
DiGiovanni, John, et al., “Deregulated expression of insulin-like growth factor I in prostate epithelium leads to neoplasia in transgenic mice,” Proc. Natl. Acad. Sci. USA, 97:3455-3460 (2000).
Drexhage, H.A. & Wulffraat, N.M., “Endocrine autoimmune diseases,” Netherlands Journal of Medicine, 45:285-293 (1994).
Kim, Bhumsoo, et al., “Insulin receptor substrate 2 and she play different roles in insulin-like growth factor I signaling,” Journal of Biological Chemistry, 273:34543-34550 (1998).
Smith, Lois E., et al., “Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor,” Nature Medicine, 5:1390-1395 (1999).
Tappy, Luc, et al., “Antibodies to insulin-like growth factor I receptors in diabetes and other disorders,” Diabetes, 37:1708-1714 (1988).
Thompson, Kathleen, et al., “Low prevalence of autoantibodies to the insulin-like growth factor I receptor in children with short stature,” Pediatric Research, 32:455-459 (1992).
Weightman, David R., et al., “Autoantibodies to IGF-1 binding sites in thyroid associated opthalmopathy,” Autoimmunity, 16:251-257 (1993).
Wraight, Christopher, et al., “Reversal of epidermal hyperproliferation in psoriasis by insulin like growth factor I receptor antisense oligonucleotides,” Nature Biotechnology, 18 :521-526 (2000).
Altschul et al., “Basic local alignment search tool,”Journal of Molecular Biology, 215(1):403 410(1990).
Altschul et al., “Gapped BLAST and PSI-BLAST: a new generation of protein database search programs,”Nucleic Acids Research, 25(17):3389-402 (1997).
Arteaga et al., “Interference of the IGF system as a strategy to inhibit breast cancer growth,”Breast Cancer Research Treatment, 22:101-106 (1992).
Arteaga et al., “Blockade of the type I somatomedin receptor inhibits growth of human breast ca
Cohen Bruce D.
Gualberto Antonio
Melvin Carrie L.
Roberts M. Luisa
Halvorson Mark
Pfizer Inc
Yu Misook
Zhang Austin W.
Zielinski Bryan C.
LandOfFree
Combination treatment for non-hematologic malignancies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combination treatment for non-hematologic malignancies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination treatment for non-hematologic malignancies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4063843